WestEnd Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.44K Hold
34
﹤0.01% 141
2025
Q4
$2.7K Sell
34
-4
-11% -$315 ﹤0.01% 134
2025
Q3
$2.87K Sell
38
-16
-30% -$1.1K ﹤0.01% 127
2025
Q2
$3.73K Buy
54
+5
+10% +$328 ﹤0.01% 116
2025
Q1
$3.32K Buy
49
+32
+188% +$1.92K ﹤0.01% 122
2024
Q4
$763 Buy
17
+3
+21% +$168 ﹤0.01% 147
2024
Q3
$880 Sell
14
-2
-13% -$117 ﹤0.01% 136
2024
Q2
$945 Sell
16
-4
-20% -$250 ﹤0.01% 124
2024
Q1
$1.59K Hold
20
﹤0.01% 96
2023
Q4
$1.58K Buy
20
+2
+11% +$142 ﹤0.01% 99
2023
Q3
$1.26K Buy
+18
New +$1.27K ﹤0.01% 100
2023
Q1
Sell
-16
Closed -$1.34K 93
2022
Q4
$1.49K Sell
16
-1
-6% -$96 ﹤0.01% 85
2022
Q3
$2K Buy
17
+1
+6% +$99 ﹤0.01% 84
2022
Q2
$1.48K Buy
+16
New +$1.56K ﹤0.01% 93
2022
Q1
Sell
-10
Closed -$1.05K 99
2021
Q4
$1.03K Buy
+10
New +$924 ﹤0.01% 107
2021
Q3
Hold
0
106
2021
Q2
Hold
0
106
2019
Q4
Sell
-22
Closed -$1.39K 61
2019
Q3
$1.39K Buy
+22
New +$1.3K ﹤0.01% 68
2017
Q1
Sell
-667,802
Closed -$52.7M 39
2016
Q4
$52.7M Sell
667,802
-80,727
-11% -$6.53M 4.2% 17
2016
Q3
$66.6M Sell
748,529
-225,818
-23% -$21.3M 4.78% 16
2016
Q2
$93.3M Sell
974,347
-22,516
-2% -$2.24M 4.95% 10
2016
Q1
$103M Sell
996,863
-20,868
-2% -$2.03M 5.01% 7
2015
Q4
$99.5M Buy
1,017,731
+22,807
+2% +$2.23M 4.88% 10
2015
Q3
$96M Sell
994,924
-52,074
-5% -$5.47M 4.86% 11
2015
Q2
$110M Sell
1,046,998
-26,553
-2% -$2.71M 5.08% 10
2015
Q1
$111M Sell
1,073,551
-155,199
-13% -$15.7M 4.98% 11
2014
Q4
$118M Sell
1,228,750
-5,472
-0.4% -$482K 5.41% 2
2014
Q3
$98.2M Sell
1,234,222
-93,673
-7% -$7.38M 4.96% 10
2014
Q2
$100M Sell
1,327,895
-118,521
-8% -$8.96M 4.91% 18
2014
Q1
$108M Sell
1,446,416
-605,312
-30% -$42.8M 5.29% 2
2013
Q4
$147M Sell
2,051,728
-454,104
-18% -$29.2M 5.31% 2
2013
Q3
$142M Sell
2,505,832
-93,853
-4% -$5.59M 4.66% 15
2013
Q2
$149M Buy
+2,599,685
New +$151M 4.89% 13

Other funds holding CVS

WestEnd Advisors's CVS Position: Q1 2026 in Review

WestEnd Advisors held its CVS Health (CVS) position steady in Q1 2026 at 34 shares worth $2.44K. The position accounts for ﹤0.01% of the portfolio, ranked #141.

WestEnd Advisors first reported a position in CVS in Q2 2013 and has held it in 31 quarters since. The position peaked at $149M in Q2 2013. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • WestEnd Advisors held 34 shares of CVS Health worth $2.44K as of Q1 2026.
  • WestEnd Advisors left its CVS Health share count unchanged in Q1 2026.
  • CVS Health made up ﹤0.01% of WestEnd Advisors's portfolio in Q1 2026, its #141 holding.
  • WestEnd Advisors first reported a position in CVS Health in Q2 2013 and has held it in 31 quarters since.
  • WestEnd Advisors's CVS Health position peaked at $149M in Q2 2013.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on WestEnd Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.